Medicare Enrolled
Dr. Derrick Su, MD
Optician · Fountain Valley, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Su from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Su?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Su
Dr. Derrick Su is an optician specialist in Fountain Valley, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Su performed 2,715 Medicare services across 321 unique beneficiaries.
Between the years covered by Open Payments, Dr. Su received a total of $45,427 from 106 pharmaceutical and/or device companies across 2025 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Su is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 30% volume in CA
$45,427 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,715
Medicare services
Top 30% in CA for optician
321
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~194 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,020 | $0 | $5 |
| Anti-nausea injection (ondansetron/Zofran) | 712 | $0 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
293 | $101 | $250 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
167 | $118 | $290 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
163 | $138 | $300 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
122 | $26 | $75 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
95 | $100 | $225 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
91 | $59 | $130 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $65 | $125 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $136 | $330 |
| New patient office visit, complex (60-74 min) | 14 | $163 | $375 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.0% high complexity
63.8% medium
22.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$45,427
Total received (2018-2024)
Avg $6,490/year across 7 years
Top 5% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
106
Companies
2,025
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$36,398 (80.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,172 (15.8%)
Other
Charitable contributions, space rental, and other categories
$1,630 (3.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$228 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,717
2023
$8,781
2022
$7,666
2021
$6,807
2020
$4,309
2019
$4,777
2018
$3,370
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,630
AstraZeneca Pharmaceuticals LP
$633
Janssen Biotech, Inc.
$587
Alexion Pharmaceuticals, Inc.
$495
Celgene Corporation
$396
Merck Sharp & Dohme LLC
$379
ABBVIE INC.
$368
Astellas Pharma US Inc
$366
Eisai Inc.
$346
Incyte Corporation
$322
PFIZER INC.
$321
Lilly USA, LLC
$303
Takeda Pharmaceuticals U.S.A., Inc.
$280
GlaxoSmithKline, LLC.
$271
Gilead Sciences, Inc.
$239
Regeneron Healthcare Solutions, Inc.
$231
Daiichi Sankyo Inc.
$194
E.R. Squibb & Sons, L.L.C.
$193
PUMA BIOTECHNOLOGY, INC.
$191
SOBI, INC
$189
Exelixis Inc.
$180
Karyopharm Therapeutics Inc.
$152
Bayer Healthcare Pharmaceuticals Inc.
$143
ARRAY BIOPHARMA INC
$104
Coherus Biosciences Inc.
$97
Genentech USA, Inc.
$96
Mirati Therapeutics, Inc.
$73
Sumitomo Pharma America, Inc.
$66
Aveo Pharmaceuticals, Inc.
$66
EMD Serono, Inc.
$64
BeiGene USA, Inc.
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$56
Genmab U.S., Inc.
$56
Stemline Therapeutics Inc.
$51
TAIHO ONCOLOGY, INC.
$45
SpringWorks Therapeutics, Inc.
$42
Ipsen Biopharmaceuticals, Inc
$38
Kite Pharma, Inc.
$34
TerSera Therapeutics LLC
$34
Blueprint Medicines Corporation
$33
Tempus AI, Inc
$29
Verity Pharmaceuticals Inc.
$29
PharmaEssentia USA Corporation
$27
Rigel Pharmaceuticals, Inc.
$25
JAZZ PHARMACEUTICALS INC.
$24
Agios Pharmaceuticals, Inc.
$24
Fennec Pharmaceuticals, Inc.
$23
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
RECORDATI_RARE_DISEASES_INC.
$22
Emmaus Medical, Inc.
$21
SERVIER PHARMACEUTICALS LLC
$19
GENZYME CORPORATION
$15
Spectrum Pharmaceuticals Inc.
$14
Top 3 companies account for 29.3% of 2024 payments
All-time payments by company (2018-2024) ›
Eisai Inc.
$3,209
Novartis Pharmaceuticals Corporation
$3,149
Bayer HealthCare Pharmaceuticals Inc.
$2,837
AstraZeneca Pharmaceuticals LP
$2,279
EISAI INC.
$2,276
E.R. Squibb & Sons, L.L.C.
$1,999
Incyte Corporation
$1,975
Celgene Corporation
$1,908
Amgen Inc.
$1,576
PFIZER INC.
$1,470
Lilly USA, LLC
$1,269
Takeda Pharmaceuticals U.S.A., Inc.
$1,165
Genentech USA, Inc.
$1,156
Gilead Sciences, Inc.
$1,120
Janssen Biotech, Inc.
$1,085
Merck Sharp & Dohme Corporation
$995
Astellas Pharma US Inc
$942
Exelixis Inc.
$900
Pharmacyclics LLC, An AbbVie Company
$781
Alexion Pharmaceuticals, Inc.
$765
Merck Sharp & Dohme LLC
$759
Seagen Inc.
$747
GlaxoSmithKline, LLC.
$687
Regeneron Healthcare Solutions, Inc.
$652
Daiichi Sankyo Inc.
$520
Pharmacyclics LLC, an AbbVie Company
$513
ABBVIE INC.
$486
ARRAY BIOPHARMA INC
$473
Karyopharm Therapeutics Inc.
$468
GENZYME CORPORATION
$418
Bayer Healthcare Pharmaceuticals Inc.
$390
Boehringer Ingelheim Pharmaceuticals, Inc.
$366
Kite Pharma, Inc.
$337
PUMA BIOTECHNOLOGY, INC.
$313
NOVARTIS PHARMACEUTICALS CORPORATION
$311
Rigel Pharmaceuticals, Inc.
$297
EMD Serono, Inc.
$256
SOBI, INC
$189
Sobi, Inc
$189
Seattle Genetics, Inc.
$187
AbbVie Inc.
$176
Ipsen Biopharmaceuticals, Inc
$173
Blueprint Medicines Corporation
$172
Stemline Therapeutics Inc.
$162
AVEO Pharmaceuticals, Inc.
$141
Jazz Pharmaceuticals Inc.
$136
Array BioPharma Inc.
$128
Aveo Pharmaceuticals, Inc.
$112
Clovis Oncology, Inc.
$107
Dendreon Pharmaceuticals LLC
$104
Myovant Sciences Inc.
$101
Coherus Biosciences Inc.
$97
MEDIVATION FIELD SOLUTIONS LLC
$93
MorphoSys, US Inc.
$89
TerSera Therapeutics LLC
$89
Mirati Therapeutics, Inc.
$87
Genmab U.S., Inc.
$83
Foundation Medicine, Inc.
$83
JAZZ PHARMACEUTICALS INC.
$81
Teva Pharmaceuticals USA, Inc.
$81
BeiGene USA, Inc.
$78
Puma Biotechnology, Inc.
$77
Octapharma USA, Inc.
$74
CTI BioPharma Corp.
$72
SANOFI-AVENTIS U.S. LLC
$70
Sumitomo Pharma America, Inc.
$66
Partner Therapeutics, Inc.
$63
Kyowa Kirin, Inc.
$59
Organon LLC
$58
Agios Pharmaceuticals, Inc.
$58
Epizyme, Inc.,
$54
Verity Pharmaceuticals Inc.
$52
Dova Pharmaceuticals
$51
RECORDATI_RARE_DISEASES_INC.
$46
TAIHO ONCOLOGY, INC.
$45
SUN PHARMACEUTICAL INDUSTRIES INC.
$42
SpringWorks Therapeutics, Inc.
$42
MACROGENICS, INC.
$40
AMAG Pharmaceuticals, Inc.
$39
Lexicon Pharmaceuticals, Inc.
$38
Otsuka America Pharmaceutical, Inc.
$35
Pharmacosmos Therapeutics Inc.
$33
Spectrum Pharmaceuticals Inc.
$33
SERVIER PHARMACEUTICALS LLC
$32
Deciphera Pharmaceuticals Inc.
$30
Tempus AI, Inc
$29
ImmunoGen, Inc.
$28
CHIESI USA, INC.
$27
PharmaEssentia USA Corporation
$27
Amneal Pharmaceuticals LLC
$27
Myriad Genetic Laboratories, Inc.
$26
GE HealthCare
$23
Catalyst Pharmaceuticals, Inc.
$23
Fennec Pharmaceuticals, Inc.
$23
Emmaus Medical, Inc.
$21
Mylan Institutional Inc.
$21
Progenics Pharmaceuticals, Inc.
$19
TG THERAPEUTICS, INC.
$19
West Therapeutics Development, LLC
$18
Immunomedics, Inc.
$18
Taiho Oncology, Inc.
$16
Acrotech Biopharma LLC
$16
INSYS Therapeutics Inc
$14
GE HEALTHCARE
$13
Servier Pharmaceuticals LLC
$12
Mylan Pharmaceuticals Inc.
$11
Top 3 companies account for 20.2% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Asparlas · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · Elahere · Endari · Enhertu · Epkinly · FASLODEX · FERAHEME · FERRIPROX · FERRIPROX 500ML BOTTLE · FIRDAPSE · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Fulphila · GAMIFANT · GAVRETO · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lazanda · Lenvima · Leukine · Lunsumio · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · Monoferric · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORENCIA · ORGOVYX · Onivyde · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · Poteligeo · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · ROLVEDON · ROZLYTREK · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNAGIS · SYNDROS · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vanflyta · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zoladex · Zydelig · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for optician in CA.
Geographic Context
Opticians within 10 mi
1,016
Per 100K population
32.1
County median income
$113,702
Nearest hospital
UCI HEALTH - FOUNTAIN VALLEY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Su is a clinical cardiology specialist, with above-average Medicare volume (top 30% in CA), with low-engagement industry engagement in the top 5% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Su experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Su performed 1,020 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Su receive payments from pharmaceutical companies?
Yes. Dr. Su received a total of $45,427 from 106 companies across 2,025 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Su's costs compare to other opticians in Fountain Valley?
Dr. Su's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Su) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Fountain Valley
Browse opticians in Fountain Valley ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Eisai Inc. Payments to Doctors
See all physicians who received payments from Eisai Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology